April 15, 2026
Who Will Pay for Your Digital Health Product? CMS Just Answered.
The ACCESS Model Creates the First Specific, Measurable Revenue Pathway for Chronic Care Technology
Insights
Thoughts on healthcare operations, product strategy, and the transition to value-based care.
AcquireNowInsights Dept.
January 22, 2026
Founder-Led Sales: The Path to Product-Market Fit
If you’re a founder struggling to find that bridge between your product and the market, let’s talk about applying the Clarity Framework to your GTM strategy.
November 5, 2025
The Clarity Mandate: Healthtech 2025 Demands Proof Over Promise
In 2025, the fundraising focus has decisively moved toward operational and administrative solutions: revenue cycle, billing, coding, and documentation tools that work inside the walls of healthcare. Adoption is rising and buying cycles are shortening because these solutions deliver immediate, measurable value.
October 9, 2025
GTM Strategy and Commercial Leadership for Point-of-Care Diagnostics
With plans to launch a rapid STI test next year, Scout Health needed a structured approach to commercialization, stakeholder engagement, and marketing execution.
September 30, 2025
From Service Revenue to SaaS Foundation
Built investor-ready GTM positioning that transformed one-time credentialing services into a scalable SaaS platform. Doubled subscription revenue in 60 days while reducing manual LinkedIn engagement by 80% through smart automation.
September 21, 2025
Leading Growth at the Intersection of Clinical and Commercial
When clinical credibility and commercial strategy aren't connected, revenue suffers. This case study details how integrated marketing and commercial leadership rebuilt that connection at Navigating Cancer, generating $12M in contracted engagements and opening a new $1M per clinic revenue stream.
January 8, 2025
From DTC to Doctor-Led GTM
Silene Biotech pioneered a novel direct‑to‑consumer (DTC) stem‑cell preservation service—freezing healthy cells today to enable future regenerative therapies. While early adopters (biohackers and tech innovators) embraced the concept, broader growth hinged on capturing the “baby boomer” market, a demographic that relies on physician guidance for medical decisions.